To overcome this, innovative lung-specific delivery systems are crucial
10.1016/j.toxlet.2021.04.018 29 GabayC.SmithM.EidlenD.ArendW
Although semaglutide and tirzepatide are both injectable medications designed to treat type 2 diabetes and support weight loss, they work in different ways
Employers discontinuing coverage of GLP-1 medications should be aware that the health benefits their members attain will likely be lost over a little more than a year unless the members find a way to continue on these medications.
Consequently, on top of the beneficial effect of weight loss caused by GLP-1 analogues these drugs also cause a substantial reduction of the glycemic load (GL = carbohydrate intake X Glycemic index), which per se reduces hyperinsulinemia and causes weight loss [22], reduce diabetes risk [23], inflammation [24], and cardiovascular risk [25]
Feel free to ask about the safety protocols we follow, the types of vitamin B12 used, and the ongoing support and follow-up appointments we provide